XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 16.06.2025

The following instruments on Boerse Frankfurt do have their last trading day on 16.06.2025
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 16.06.2025

ISIN Name
GB00BLNNFY18 HARMONY ENERGY INCOME TR.
LU0039632921 UNIRENTACORP INH. A
LU0055734320 UNIRESERVE: EURO A
LU0059863547 UNIRESERVE: USD
LU0192293511 UNIEURORENTA REAL ZINS A
LU0192294089 UNIEURORENTA REAL -NET-A
LU0247467987 UNIRESERVE:EO-CORPORATES
NL0012170237 PLAYA HOTELS+RES. EO -,10
SE0014855292 READLY INTERNATIONAL AB
US23344D1081 DADA NEXUS LTD ADS
US31572Q8087 FIBROGEN INC. DL-,01
US3498531017 FORWARD AIR CORP. DL-,01
US75382E1091 RAPT THERAP. INC.DL-,0001
US81728A1088 SENSEI BIOTHER. DL -,0001

Zeit	Aktuelle Nachrichten
10.11.	FibroGen steigert Umsatz im Q3 2025 und senkt Kosten drastisch
10.11.	FIBROGEN INC - 10-Q, Quarterly Report
06.11.	FIBROGEN INC - 8-K, Current Report
03.11.	FibroGen, Inc.: FibroGen to Report Third Quarter 2025 Financial Results
02.10.	XFRA 1FG0: WIEDERAUFNAHME/RESUMPTION	FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen

Zeit

Aktuelle Nachrichten

10.11.

FibroGen steigert Umsatz im Q3 2025 und senkt Kosten drastisch

10.11.

FIBROGEN INC - 10-Q, Quarterly Report

06.11.

FIBROGEN INC - 8-K, Current Report

03.11.

FibroGen, Inc.: FibroGen to Report Third Quarter 2025 Financial Results

02.10.

XFRA 1FG0: WIEDERAUFNAHME/RESUMPTION

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen

Zeit	Aktuelle Nachrichten
06.11.	Forward Air: Jefferies senkt Kursziel wegen Marktvolatilität auf 30 US-Dollar
06.11.	Forward Air stock price target lowered to $30 by Jefferies on market volatility
06.11.	Forward Air says strategic review, potential sale still on track
06.11.	Forward Air outlines ongoing strategic review and cost initiatives as consolidated EBITDA reaches $78M in Q3 2025
06.11.	Forward Air Q3 2025 slides: stable EBITDA amid freight challenges, cash flow improves

Zeit

Aktuelle Nachrichten

06.11.

Forward Air: Jefferies senkt Kursziel wegen Marktvolatilität auf 30 US-Dollar

06.11.

Forward Air stock price target lowered to $30 by Jefferies on market volatility

06.11.

Forward Air says strategic review, potential sale still on track

06.11.

Forward Air outlines ongoing strategic review and cost initiatives as consolidated EBITDA reaches $78M in Q3 2025

06.11.

Forward Air Q3 2025 slides: stable EBITDA amid freight challenges, cash flow improves

Zeit	Aktuelle Nachrichten
18.06.	Stock Exch Notice - Cancellation - Harmony Energy Income Trust PLC
17.06.	Stock Exch Notice - Suspension - Harmony Energy Income Trust plc
17.06.	Harmony Energy Income Trust - Scheme of Arrangement Becomes Effective
16.06.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 16.06.2025	The following instruments on Boerse Frankfurt do have their last trading day on 16.06.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 16.06.2025ISIN NameGB00BLNNFY18 HARMONY... ► Artikel lesen
16.06.	XFRA CAPITAL ADJUSTMENT INFORMATION - 16.06.2025	Das Instrument F62 NO0012697715 ENERGEIA AS NK 60 EQUITY wird ex Kapitalmassnahme gehandelt am 16.06.2025 The instrument F62 NO0012697715 ENERGEIA AS NK 60 EQUITY is traded ex capital adjustment on... ► Artikel lesen

Zeit

Aktuelle Nachrichten

18.06.

Stock Exch Notice - Cancellation - Harmony Energy Income Trust PLC

17.06.

Stock Exch Notice - Suspension - Harmony Energy Income Trust plc

17.06.

Harmony Energy Income Trust - Scheme of Arrangement Becomes Effective

16.06.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 16.06.2025

16.06.

XFRA CAPITAL ADJUSTMENT INFORMATION - 16.06.2025

Das Instrument F62 NO0012697715 ENERGEIA AS NK 60 EQUITY wird ex Kapitalmassnahme gehandelt am 16.06.2025 The instrument F62 NO0012697715 ENERGEIA AS NK 60 EQUITY is traded ex capital adjustment on...
► Artikel lesen

Zeit	Aktuelle Nachrichten
06.11.	RAPT Therapeutics GAAP EPS of -$0.65 beats by $0.17
06.11.	RAPT Therapeutics, Inc.: RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights	- Initiated prestIgE Phase 2b trial of ozureprubart in food allergy - Announced positive topline data from Phase 2 trial in chronic spontaneous urticaria; results showed ozureprubart at both Q8W and... ► Artikel lesen
06.11.	RAPT Therapeutics, Inc. - 10-Q, Quarterly Report
06.11.	RAPT Therapeutics, Inc. - 8-K, Current Report
28.10.	Rapt Therapeutics stock price target raised to $72 from $27 at H.C. Wainwright

Zeit

Aktuelle Nachrichten

06.11.

RAPT Therapeutics GAAP EPS of -$0.65 beats by $0.17

06.11.

RAPT Therapeutics, Inc.: RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

- Initiated prestIgE Phase 2b trial of ozureprubart in food allergy - Announced positive topline data from Phase 2 trial in chronic spontaneous urticaria; results showed ozureprubart at both Q8W and...
► Artikel lesen

06.11.

RAPT Therapeutics, Inc. - 10-Q, Quarterly Report

06.11.

RAPT Therapeutics, Inc. - 8-K, Current Report

28.10.

Rapt Therapeutics stock price target raised to $72 from $27 at H.C. Wainwright

Zeit	Aktuelle Nachrichten
17.10.	Readly appoints Chloe Rushmere as new Head of Content UK
14.10.	Q3 Operational update: Readly shows continued growth and improves accessibility in the app
05.09.	Readly: Brits say writing standards have declined with the digital era whilst reading opportunities have risen: International Literacy Day (8 September)	LONDON, Sept. 5, 2025 /PRNewswire/ -- Almost half of Brits (44 percent) believe that their writing standards have declined with technology but that their overall literacy and reading has... ► Artikel lesen
28.07.	Body Positivity: Brits Tired of Airbrushing and Two Thirds Demand more 'Normal' Body Representation - Readly Survey Reveals	LONDON, July 28, 2025 /PRNewswire/ -- Weight loss drugs, extreme workouts and protein rich diets are being well documented on social media and shaping body ideals, yet 68 percent of Brits... ► Artikel lesen
11.07.	Q2 Operational update: Readly returns to subscriber growth and has continued 2025 with robust profitability

Zeit

Aktuelle Nachrichten

17.10.

Readly appoints Chloe Rushmere as new Head of Content UK

14.10.

Q3 Operational update: Readly shows continued growth and improves accessibility in the app

05.09.

Readly: Brits say writing standards have declined with the digital era whilst reading opportunities have risen: International Literacy Day (8 September)

LONDON, Sept. 5, 2025 /PRNewswire/ -- Almost half of Brits (44 percent) believe that their writing standards have declined with technology but that their overall literacy and reading has...
► Artikel lesen

28.07.

Body Positivity: Brits Tired of Airbrushing and Two Thirds Demand more 'Normal' Body Representation - Readly Survey Reveals

LONDON, July 28, 2025 /PRNewswire/ -- Weight loss drugs, extreme workouts and protein rich diets are being well documented on social media and shaping body ideals, yet 68 percent of Brits...
► Artikel lesen

11.07.

Q2 Operational update: Readly returns to subscriber growth and has continued 2025 with robust profitability

Zeit	Aktuelle Nachrichten
Fr	Sensei shrinks workforce by 65%, terminates 3 executive roles
Fr	Sensei BioTherapeutics GAAP EPS of -$3.62
Fr	Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results	BOSTON, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics... ► Artikel lesen
Fr	Sensei Biotherapeutics, Inc. - 10-Q, Quarterly Report
Fr	Sensei Biotherapeutics, Inc. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

Sensei shrinks workforce by 65%, terminates 3 executive roles

Sensei BioTherapeutics GAAP EPS of -$3.62

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

BOSTON, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics...
► Artikel lesen

Sensei Biotherapeutics, Inc. - 10-Q, Quarterly Report

Sensei Biotherapeutics, Inc. - 8-K, Current Report

Unternehmen / Aktien	Kurs	%
FIBROGEN INC	7,200	0,00 %
FORWARD AIR CORPORATION	17,100	-3,93 %
HARMONY ENERGY INCOME TRUST PLC	1,070	0,00 %
RAPT THERAPEUTICS INC	24,600	0,00 %
READLY INTERNATIONAL AB	2,410	0,00 %
SENSEI BIOTHERAPEUTICS INC	9,800	0,00 %

Unternehmen / Aktien

Kurs

FIBROGEN INC

7,200

0,00 %

FORWARD AIR CORPORATION

17,100

-3,93 %

HARMONY ENERGY INCOME TRUST PLC

1,070

0,00 %

RAPT THERAPEUTICS INC